Bilim İlaç is a Turkish pharmaceutical company that was established in 1953. Having strategic importance in the pharmaceutical sector, the company is involved in the production and marketing of pharmaceuticals. It ranks third among the 300 establishments in the Turkish pharmaceutical industry, demonstrating consistently above-market performance and sustained growth. Bilim İlaç operates production in two separate facilities; Bilim Çerkezköy, approved by the German Ministry of Health, is one of Turkey's most important penicillin production facilities, while Bilim Gebze, approved by the UK Ministry of Health, is Turkey's largest, newest, and most environmentally friendly pharmaceutical production facility. With a 4,500 square meter laboratory area, Bilim İlaç contributes significantly to the Turkish economy through the development of new products at the largest R&D center in the Turkish pharmaceutical industry. The company exports to more than 50 countries and has representative offices in Moldova, Georgia, Bosnia and Herzegovina, and Albania.
Bilim İlaç prioritizes quality in a sensitive sector directly related to human health. It also embraces respect for future generations as a core company value. With its range of activities across Biotechnology, Health Care, Manufacturing, and Pharmaceutical industries, the company holds a prominent position in the Turkish economy. Although specific financial details are not available at this time, the company's steady growth, international presence, and focus on research and development make it an intriguing prospect for potential investors.
There is no investment information
No recent news or press coverage available for Bilim İlaç.